Search

everythinglearnresearchcommunity

for

Search:↓

Free fatty acids may increase androgen production, potentially contributing to polycystic ovary syndrome.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.

The PCOS-specific questionnaire needs more work to fully measure quality of life in clinical trials.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Obese women with PCOS have lower vitamin D levels.

Obese and lean women with PCOS have different symptoms and need different treatments.

DNA profiling in forensics has improved, but predicting physical traits and ancestry from DNA has limitations and requires ethical consideration.

PCOS is caused by both genetics and environmental factors like diet and obesity.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

Women with PCOS who have low SHBG are more likely to have low good cholesterol and metabolic syndrome.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Low and ultralow doses of flutamide can cause liver damage in young women with high androgen levels, regardless of dose or birth control use, with higher risk for those with higher BMI and liver enzyme levels before treatment.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

Longer GGN repeats in the androgen receptor gene are linked to polycystic ovary syndrome.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Genetic variants in CYP genes may worsen PCOS symptoms.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Most women referred for excess male hormone symptoms had polycystic ovary syndrome (PCOS), with other conditions being less common.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

PCOS is a common disorder in women causing symptoms like irregular periods and weight gain, with management possible through lifestyle changes and medication.

PCOS-related infertility is managed with lifestyle changes and medications.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.